This Special Issue of the Journal of the Brain Sciences aims to collate recent clinical and basic research that provides new information on the ototoxic effects of drugs (including biologics), as well as the lesser-known disease entities associated with hearing impairment, such as (but not limited to) temporomandibular joint disorders, kidney diseases, Hashimoto’s disease, or mitochondrial diseases. New biomarkers for hearing loss are also covered.
Prof. Dr. Agnieszka Szczepek, the Guest Editor of this special issue, said:
Hearing impairment is a common condition that has received increased attention recently. Scientific studies showing a link between untreated hearing loss and the development of dementia have been particularly instrumental in raising the profile of hearing loss. The classic causes of hearing loss or deafness are genetic predisposition, ototoxic substances and drugs, noise, and aging. Some diseases, such as diabetes, multiple sclerosis, autoimmune diseases, or certain cancers, are also affected by the development of hearing loss. Because this field of research is evolving exponentially, a thematic collection of the latest discoveries could help us keep up to date with these developments.
The main topics comprise:
To see the published papers so far click here
For further information, please contact:
Hashir International Institute, 167-169 Great Portland Street, 5th Floor, London, W1W 5PF
Hashir International Institute, 54 Quarry Street, Guildford. GU1 3UA
admin@hashirtinnitusclinic.com
About Hashir International Institute:
Hashir International is an independent research institute and treatment centre dedicated to improving the diagnostic process and rehabilitation programs for patients experiencing misophonia, tinnitus and hyperacusis. They offer specialist training courses, ethical review of research proposals, research design, research sponsorship, and supervising MSc and PhD students.
